Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:25:59 EDT Thu 02 May 2024
Enter Symbol
or Name
USA
CA



Z:NBY - NOVABAY PHARMACEUTICALS INC - https://investors.novabay.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NBY - Z0.10.082·0.100.50.0896    1.28  0.065May 01Apr 2215 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-22 06:57U:NBYNews ReleaseNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
2024-04-19 18:00U:NBYNews ReleaseNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
2024-04-17 06:59U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
2024-03-29 02:38U:NBYSEDAR MD & ASEDAR MD & A
2024-03-29 02:31U:NBYSEDAR Annual Information FormSEDAR Audited Annual Financial Statements
2024-03-26 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
2024-03-25 18:38U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
2024-03-14 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
2024-03-13 07:00U:NBYNews ReleaseNovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
2024-01-30 09:00U:NBYNews ReleaseNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
2024-01-09 09:16U:NBYNews ReleaseNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma ¢ € ™s Extensive Distributor Network
2023-12-06 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic Membranes
2023-11-09 17:00U:NBYSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-09 16:50U:NBYSEDAR Interim MD & ASEDAR Interim MD & A
2023-11-09 16:05U:NBYNews ReleaseNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial Results
2023-11-02 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023
2023-10-11 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova Programs
2023-10-02 06:50U:NBYNews ReleaseNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
2023-09-14 08:00U:NBYNews ReleaseNovaBay Pharmaceuticals Announces Commercial Launch of Avenova ‚ ® Allograft